MICHAEL G GREY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL G GREY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL G GREY. MICHAEL G GREY is Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in Horizon Pharma plc ($HZNP) and in Mirati Therapeutics, Inc. ($MYG) and Director in Mirati Therapeutics, Inc. ($MYG) and Executive Chairman in Reneo Pharmaceuticals, Inc. ($RPHM) and Director in Mirum Pharmaceuticals, Inc. ($MIRM) and Executive Chairman in Mirum Pharmaceuticals, Inc. ($MIRM).
Latest Insider Trading Transactions of MICHAEL G GREY
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BMRN, HZNP, MYG, MIRM, RPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 30 2021 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Option Exercise | M | 0.00 | 11,098 | 0 | 0 | |
Apr 30 2021 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Option Exercise | A | 0.00 | 4,223 | 0 | 4,223 | |
Apr 30 2021 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Payment of Exercise | F | 94.62 | 2,993 | 283,198 | 70,395 | 73.4 K to 70.4 K (-4.08 %) |
Apr 30 2021 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Buy | M | 0.00 | 11,098 | 0 | 73,388 | 62.3 K to 73.4 K (+17.82 %) |
Apr 15 2021 | RPHM | Reneo Pharmaceutic ... | GREY MICHAEL G | Executive Chairman | Option Exercise | C | 0.00 | 90,222 | 0 | 0 | |
Apr 15 2021 | RPHM | Reneo Pharmaceutic ... | GREY MICHAEL G | Executive Chairman | Buy | C | 0.00 | 20,162 | 0 | 444,762 | 424.6 K to 444.8 K (+4.75 %) |
Apr 13 2021 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Option Exercise | M | 2.37 | 15,000 | 35,550 | 5,000 | |
Apr 13 2021 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Sell | S | 90.28 | 15,000 | 1,354,200 | 0 | 15 K to 0 (-100.00 %) |
Apr 13 2021 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Buy | M | 2.37 | 15,000 | 35,550 | 15,000 | 0 to 15 K |
Apr 12 2021 | RPHM | Reneo Pharmaceutic ... | GREY MICHAEL G | Executive Chairman | Option Exercise | A | 15.00 | 14,000 | 210,000 | 14,000 | |
Jan 20 2021 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Option Exercise | A | 214.47 | 2,155 | 462,183 | 2,155 | ||
Jan 20 2021 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Grant | A | 0.00 | 1,475 | 0 | 5,731 | 4.3 K to 5.7 K (+34.66 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Option Exercise | M | 16.84 | 10,900 | 183,556 | 0 | ||
Dec 16 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 249.42 | 89 | 22,198 | 4,256 | 4.3 K to 4.3 K (-2.05 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 248.55 | 1,019 | 253,269 | 4,345 | 5.4 K to 4.3 K (-19.00 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 247.62 | 1,997 | 494,502 | 5,364 | 7.4 K to 5.4 K (-27.13 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 246.73 | 1,807 | 445,834 | 7,361 | 9.2 K to 7.4 K (-19.71 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 245.11 | 1,284 | 314,725 | 9,168 | 10.5 K to 9.2 K (-12.28 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 244.45 | 1,653 | 404,083 | 10,452 | 12.1 K to 10.5 K (-13.66 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 243.35 | 1,815 | 441,671 | 12,105 | 13.9 K to 12.1 K (-13.04 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 242.29 | 857 | 207,641 | 13,920 | 14.8 K to 13.9 K (-5.80 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 241.22 | 379 | 91,422 | 14,777 | 15.2 K to 14.8 K (-2.50 %) | |
Dec 16 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Buy | M | 16.84 | 10,900 | 183,556 | 15,156 | 4.3 K to 15.2 K (+256.11 %) | |
Aug 07 2020 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Option Exercise | M | 3.95 | 1,755 | 6,932 | 0 | |
Aug 07 2020 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Sell | S | 73.35 | 1,755 | 128,729 | 0 | 1.8 K to 0 (-100.00 %) |
Aug 07 2020 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Buy | M | 3.95 | 1,755 | 6,932 | 1,755 | 0 to 1.8 K |
Aug 05 2020 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | M | 26.49 | 2,500 | 66,225 | 5,000 | |
Aug 05 2020 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 120.35 | 2,500 | 300,875 | 42,840 | 45.3 K to 42.8 K (-5.51 %) |
Aug 05 2020 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Buy | M | 26.49 | 2,500 | 66,225 | 45,340 | 42.8 K to 45.3 K (+5.84 %) |
Jul 22 2020 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Option Exercise | M | 3.95 | 1,755 | 6,932 | 1,755 | |
Jul 22 2020 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Sell | S | 60.00 | 1,755 | 105,300 | 0 | 1.8 K to 0 (-100.00 %) |
Jul 22 2020 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Buy | M | 3.95 | 1,755 | 6,932 | 1,755 | 0 to 1.8 K |
Jun 26 2020 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Option Exercise | M | 3.95 | 1,755 | 6,932 | 3,510 | |
Jun 26 2020 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Sell | S | 55.00 | 1,755 | 96,525 | 0 | 1.8 K to 0 (-100.00 %) |
Jun 26 2020 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Buy | M | 3.95 | 1,755 | 6,932 | 1,755 | 0 to 1.8 K |
Jun 15 2020 | MIRM | Mirum Pharmaceutic ... | GREY MICHAEL G | Director | Option Exercise | A | 16.71 | 17,000 | 284,070 | 17,000 | |
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 4,300 | 0 | 42,840 | 38.5 K to 42.8 K (+11.16 %) |
May 04 2020 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Option Exercise | M | 0.00 | 15,390 | 0 | 0 | |
May 04 2020 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Option Exercise | A | 0.00 | 11,098 | 0 | 11,098 | |
May 04 2020 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Buy | M | 0.00 | 15,390 | 0 | 62,290 | 46.9 K to 62.3 K (+32.81 %) |
Jan 07 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Option Exercise | A | 113.20 | 4,000 | 452,800 | 4,000 | ||
Jan 07 2020 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Grant | A | 0.00 | 2,000 | 0 | 4,256 | 2.3 K to 4.3 K (+88.65 %) | |
Jan 02 2020 | MIRM | Mirum Pharmaceutic ... | GREY MICHAEL G | Director | Option Exercise | A | 24.52 | 100,000 | 2,452,000 | 100,000 | |
Nov 14 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Option Exercise | M | 16.84 | 3,500 | 58,940 | 10,900 | ||
Nov 14 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 102.44 | 3,042 | 311,622 | 2,256 | 5.3 K to 2.3 K (-57.42 %) | |
Nov 14 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Buy | M | 16.84 | 3,500 | 58,940 | 5,298 | 1.8 K to 5.3 K (+194.66 %) | |
Aug 14 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Option Exercise | M | 16.84 | 3,500 | 58,940 | 14,400 | ||
Aug 14 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 93.98 | 260 | 24,434 | 1,798 | 2.1 K to 1.8 K (-12.63 %) | |
Aug 14 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 93.18 | 650 | 60,569 | 2,058 | 2.7 K to 2.1 K (-24.00 %) | |
Aug 14 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 92.34 | 1,100 | 101,575 | 2,708 | 3.8 K to 2.7 K (-28.89 %) | |
Aug 14 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 91.20 | 1,032 | 94,119 | 3,808 | 4.8 K to 3.8 K (-21.32 %) | |
Aug 14 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Buy | M | 16.84 | 3,500 | 58,940 | 4,840 | 1.3 K to 4.8 K (+261.19 %) | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | GREY MICHAEL G | Executive Chairman | Option Exercise | C | 0.00 | 63,585 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | GREY MICHAEL G | Executive Chairman | Buy | C | 0.00 | 7,948 | 0 | 289,198 | 281.3 K to 289.2 K (+2.83 %) |
Jun 06 2019 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 4,430 | 0 | 38,540 | 34.1 K to 38.5 K (+12.99 %) |
May 15 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Option Exercise | M | 16.84 | 7,100 | 119,564 | 17,900 | ||
May 15 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 66.08 | 300 | 19,825 | 1,340 | 1.6 K to 1.3 K (-18.29 %) | |
May 15 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Sell | S | 65.26 | 5,460 | 356,314 | 1,640 | 7.1 K to 1.6 K (-76.90 %) | |
May 15 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Buy | M | 16.84 | 7,100 | 119,564 | 7,100 | 0 to 7.1 K | |
May 06 2019 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Option Exercise | M | 0.00 | 15,320 | 0 | 0 | |
May 06 2019 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Option Exercise | A | 0.00 | 15,390 | 0 | 15,390 | |
May 06 2019 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Payment of Exercise | F | 26.54 | 4,132 | 109,663 | 46,900 | 51 K to 46.9 K (-8.10 %) |
May 06 2019 | HZNP | Horizon Therapeuti ... | GREY MICHAEL G | Director | Buy | M | 0.00 | 15,320 | 0 | 51,032 | 35.7 K to 51 K (+42.90 %) |
Jan 22 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Option Exercise | A | 64.14 | 11,000 | 705,540 | 11,000 | ||
Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 4,300 | 0 | 34,110 | 29.8 K to 34.1 K (+14.42 %) |
May 07 2018 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 0.00 | 15,320 | 0 | 15,320 | |
May 07 2018 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 13.87 | 32,161 | 446,073 | 32,161 | |
May 07 2018 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | M | 0.00 | 14,054 | 0 | 0 | |
May 07 2018 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Payment of Exercise | F | 13.87 | 3,790 | 52,567 | 35,712 | 39.5 K to 35.7 K (-9.59 %) |
May 07 2018 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Buy | M | 0.00 | 14,054 | 0 | 39,502 | 25.4 K to 39.5 K (+55.23 %) |
Jan 22 2018 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Option Exercise | A | 27.00 | 10,000 | 270,000 | 10,000 | ||
Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | A | 89.60 | 4,910 | 439,936 | 4,910 | |
Jun 08 2017 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 2,050 | 0 | 29,810 | 27.8 K to 29.8 K (+7.38 %) |
May 19 2017 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Director | Option Exercise | A | 3.65 | 10,000 | 36,500 | 10,000 | |
May 10 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Buy | P | 9.48 | 10,000 | 94,800 | 25,448 | 15.4 K to 25.4 K (+64.73 %) |
May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 0.00 | 14,054 | 0 | 14,054 | |
May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 15.12 | 31,153 | 471,033 | 31,153 | |
May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | M | 0.00 | 13,953 | 0 | 0 | |
May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Payment of Exercise | F | 15.12 | 3,763 | 56,897 | 15,448 | 19.2 K to 15.4 K (-19.59 %) |
May 04 2017 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Buy | M | 0.00 | 13,953 | 0 | 19,211 | 5.3 K to 19.2 K (+265.37 %) |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | A | 89.52 | 4,440 | 397,469 | 4,440 | |
Jun 08 2016 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 1,510 | 0 | 27,760 | 26.3 K to 27.8 K (+5.75 %) |
May 19 2016 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Director | Option Exercise | A | 15.72 | 10,000 | 157,200 | 10,000 | |
May 10 2016 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | M | 0.00 | 5,258 | 0 | 0 | |
May 10 2016 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Buy | M | 0.00 | 5,258 | 0 | 5,258 | 0 to 5.3 K |
May 05 2016 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 0.00 | 13,953 | 0 | 13,953 | |
May 05 2016 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 15.23 | 23,092 | 351,691 | 23,092 | |
Feb 23 2016 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | M | 38.59 | 7,500 | 289,425 | 0 | |
Feb 23 2016 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 80.00 | 7,500 | 600,000 | 26,250 | 33.8 K to 26.3 K (-22.22 %) |
Feb 23 2016 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Buy | M | 38.59 | 7,500 | 289,425 | 33,750 | 26.3 K to 33.8 K (+28.57 %) |
Nov 18 2015 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | M | 38.59 | 7,500 | 289,425 | 7,500 | |
Nov 18 2015 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 104.27 | 7,500 | 782,054 | 26,250 | 33.8 K to 26.3 K (-22.22 %) |
Nov 18 2015 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Buy | M | 38.59 | 7,500 | 289,425 | 33,750 | 26.3 K to 33.8 K (+28.57 %) |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | A | 122.27 | 3,300 | 403,491 | 3,300 | |
Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 1,100 | 0 | 26,250 | 25.2 K to 26.3 K (+4.37 %) |
May 22 2015 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Director | Option Exercise | A | 25.84 | 15,000 | 387,600 | 15,000 | |
May 08 2015 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 0.00 | 5,258 | 0 | 5,258 | |
May 08 2015 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 28.53 | 8,548 | 243,874 | 8,548 |
Page: 1